HDAC6 is an important target for neuroprotection and neuroregeneration in traumatic brain injury, stroke and neurodegenerative disorders 11-14 and HDAC inhibitors reduce the cytotoxic effects of anti-tumor agents in normal cells 53, 54. Here, HDAC6 is linked to stroke disorder.